Aetiology and pathology of clinical depression

Hospital Pharmacist

Volumn 9, Issue 8, 2002, Pages 219-222

  Shah, Premal J ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECTIVE NEUROSIS; CHILDHOOD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEGENERATIVE DISEASE; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; HEREDITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE EVENT; NERVOUS SYSTEM DEVELOPMENT; NEUROENDOCRINE SYSTEM; ONSET AGE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SOCIAL PROBLEM; STANDARDIZATION; VALIDATION PROCESS;

EID: 0036741590     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J. Long term outcome of episodes of depression. JAMA 1984;252:788-92.
2. Grove WM, Andreasen NC, Young M, Endicott J, Keller MB, Hirschfeld RMA et al. Isolation and characterisation of a nuclear depressive syndrome. Psychol Med 1987;17:471-84.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington DC:American Psychiatric Association; 1994.
4. World Health Organization. International statistical classification of diseases and related health problems. Geneva:WHO; 1992.
5. Bertelsen A, Harvald B, Hauge M.A Danish twin study of manic-depressive disorders. Br J Psychiatry 1977;130:330-51.
6. Nurnberger JI Jr, Gershon ES. Genetics. In: Paykel ES, editor. Handbook of affective disorders. New York: Guilford; 1992. pp131-48.
7. Ogilvie A, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwin GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to depression. Lancet 1996;347:731-3.
8. Brown GW, Harris T, Copeland JR. Depression and loss. Br J Psychiatry 1977;130:1-18.
9. Parker G, Hadzi-Pavlovic D. Modifications of levels of depression in mother-bereaved women by parental and marital relationships. Psychol Med 1984;14:125-35.
10. Krishnan KR, Tupler LA, McDonald WM. Background factors and clinical symptoms of major depression with silent cerebral infarction (5). Stroke 1994;25:2507a.
11. Krishnan KRR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501.
12. Cooke DJ.The significance of life events as a cause of psychological and physical disorders. In: Cooper B, editor. Psychiatric epidemiology. New York: Croom Helm; 1987. pp66-80.
13. Sapolsky RM, Krey LC, McEwen B.The neuroendocrinology of stress and ageing: the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284-301.
14. Shah PJ, Glabus MF, Goodwin GM, Ebmeier KP. Grey matter reduction in chronic, treatment resistant depression. Br J Psychiatry 1998;172:527-32.
15. Wolkowitz OM, Reus VI. Treatment of depression with antiglucocorticoid drugs. Psychosom Med 1999;61:698-711.
16. Delgado PL, Price LH, Heninger GR, Charney DS. Neurochemistry. In: Paykel ES, editor. Handbook of affective disorders. New York: Guilford; 1992. pp219-53.
17. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-13.
18. Shah PJ, Glabus MF, Goodwin GM, Ebmeier KP. Chronic, treatment resistant depression and right fronto-striatal atrophy. Br J Psychiatry, 2002;180:434-40.
19. Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-7.
20. Vogel G. New brain cells prompt new theories of depression. Science 2000:290:258-9.